Statin Intolerance in Patients With Myocardial Infarction

• Conditions: Statin Adverse Reaction

• Registration Number: NCT04069598
• Lead Sponsor: Turkish Society of Cardiology

Brief Summary

Patients with acute coronary syndrome (MI, NSTEMI, USAP) will be included. They will be screened for statin intolernace for 6 months.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2019-08-23
• Study First Submitted QC: 2019-08-23
• Study Start: 2019-08-26
• Study First Posted: 2019-08-28
• Status Verified: 2019-09
• Last Update Submitted: 2019-09-10
• Last Update Posted: 2019-09-12
• Primary Completion: 2020-03-02
• Study Completion: 2020-03-31

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 600

Inclusion Criteria

• Acute coronary syndrome

Exclusion Criteria

• Being on statin, having statin related side effects

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Statin intolerance	6 months	Number (percentage) of patients with statin intolerance

Trial Locations

Locations (4)

Haseki; 🇹🇷 Istanbul, Turkey

Siyami Ersek; 🇹🇷 Istanbul, Turkey

Tepecik; 🇹🇷 Izmir, Turkey

Ozcan Basaran; 🇹🇷 Mugla, Turkey